Showing 101-110 of 2439 results for "".
From the Editor: New Additions to Practical Neurology® in 2018
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/from-the-editor-new-additions-to-practical-neurology-in-2018/30309/Where #Neurology and Culture IntersectCerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations
https://practicalneurology.com/diseases-diagnoses/stroke/cerebrovascular-inflammatory-conditions-diagnostic-challenges-and-treatment-considerations/36478/Abbas Kharal, MD, MPH, Neurologist at Cleveland Clinic Neurological Institute, Cleveland, OH, provides a review of cerebrovascular inflammatory conditions, with an emphasis on diagnostic challenges, the evolving treatment landscape, and the use of imaging and clinical responses to assist cliniciansNeurology Q&A: What Neurologists Should Know About Headache Patients and Complimentary Medicine
https://practicalneurology.com/diseases-diagnoses/headache-pain/neurology-qa-what-neurologists-should-know-about-headache-patients-and-complimentary-medicine/30804/Those who suffer from headaches may be more likely to use CAM than others are. Here's what research shows.A Q&A with Rebecca E. Wells, MD, MPHSeeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin TherapeuticsFrontal Temporal Dementia: A Disease in Progress
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0109_11-php/30963/Increasing knowledge about FTD has important practical implications for neurologists who must accurately diagnose and manage the condition. By Ronald Devere, MDConcussion and Epilepsy: What is the Link?
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/concussion-and-epilepsy-what-is-the-link/30769/Individuals who suffer a traumatic brain injury are at increased risk for developing seizures. Here's an update to the current evidence and implications for monitoring.Insights from G. Alexander Hishaw, MDAdvancing MOGAD Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advancing-mogad-care/60954/What do the latest METEOROID trial results mean for neurologists treating myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)? Michael Levy, MD, Massachusetts General Hospital, Boston, MA, discusses relapse prevention, diagnostic challenges, and the future of MOGAD management witRett Syndrome: Magnolia and Her Family's Experience
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rett-syndrome-magnolia-and-her-familys-experience/30097/AJ Tesler shares the story of his daughter, Magnolia, who is living with Rett syndrome. As a parent and caregiver, AJ provides his perspective throughout the diagnostic and therapeutic journey for Rett syndrome and is joined by Rett syndrome expert Carey Fu, MD, Pediatric Neurologist at Vanderbilt UThe Importance of Early Diagnosis and Treatment of Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-importance-of-early-diagnosis-and-treatment-of-alzheimer-disease/35436/Linda Shows, a semi-retired nurse who lives with mild cognitive impairment, and her physician, Wendell Helveston, MD, Hattiesburg Clinic, Hattiesburg, MS, discuss the importance of early diagnosis and treatment in Alzheimer disease, including other factors that can help patients thrive when living wModern Glioma Management: Integrating Molecular Markers and New Targeted Therapies
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/modern-glioma-management-integrating-molecular-markers-and-new-targeted-therapies/48967/Patrick Y. Wen, MD, Dana-Farber Cancer Institute, Boston, MA, discusses current standards of care for low- and high-grade gliomas, including the importance of comprehensive molecular testing, the World Health Organization classification of tumors of the central nervous system, and newly available th